baber/WOPTO huggingface dataset:
Patent DE-69329179-T2 (DE)
Inventor: VEGA MORILLO RAUL
IPC: G07F9/00
Filed: 1993-12-02
Granted: 2001-03-29
Abstract: Coin-operated machine for dispensing foodstuffs preserved in frozen condition and ready to be served hot in situ consisting of a casing (2) having a door (3) inside which there is a freezing unit (4) having doors and supporting elements, connected to a compressor unit (6) and a motor (30). The freezing unit (4) has, inside, trays (7) on supporting guides (8) fitted with a multiplurality of hooks (9) acting as electric resistances. On the lower side, there is a hopper (20) connected with the upper entrance of an oven (21) having an upper door (22) and a front door (23), The freezing unit contains the frozen product in a plastic package which has a ring or strip of low density arranged on the hooks (9), the assembly operating from a computer (13) acting on all the mechanisms. <IMAGE>
Patent DE-69334026-T2 (DE)
Inventor: ALBERTSEN C
IPC: C12N9/02
Filed: 1993-03-09
Granted: 2007-01-11
Abstract: An inducible promoter is used to regulate expression of a gene which is known to be critical to male fertility. The selected gene's control sequences are modified so that it is normally "off" and as a result the plants are male sterile. When it is desired to reproduce the male sterile plants, male fertility is restored by treating the plants with a non-phytotoxic chemical which induces expression of the critical gene. A critical gene is one which affects flavonol production and in particular compounds of the formula:    <IMAGE>   wherein R1, R2, R3, R4, R5, R7, and R8, are hydrogen, hydroxyl or alkoxy having from 1 to 4 carbon atoms. Particularly preferred flavonols include galangin, kaempferol, iso-rhamnetin, quercetin and morin.
Patent DE-69403080-T2 (DE)
Inventor: NEWTON JOHN REGINALD
IPC: B29C70/48
Filed: 1994-07-07
Granted: 1997-12-04
Abstract: PCT No. PCT/GB94/01475 Sec. 371 Date Mar. 22, 1996 Sec. 102(e) Date Mar. 22, 1996 PCT Filed Jul. 7, 1994 PCT Pub. No. WO95/01868 PCT Pub. Date Jan. 19, 1995A method for molding a composite article by injecting a plastics material resin into the fibers within a mold by a continuous web of fibers that is laid in a mold in such fashion that a honeycomb structure is produced without the web crossing itself.
Patent DE-69403900-T2 (DE)
Inventor: KNIGHT JAN
IPC: G01N33/50
Filed: 1994-04-07
Granted: 1998-01-15
Abstract: PCT No. PCT/GB94/00774 Sec. 371 Date Oct. 3, 1995 Sec. 102(e) Date Oct. 3, 1995 PCT Filed Apr. 7, 1994 PCT Pub. No. WO94/23296 PCT Pub. Date Oct. 13, 1994Particles that move at low Reynolds numbers are separated from a filter material on which they are adsorbed by subjecting the filter material, in a liquid medium, to agitation of sufficient magnitude to create turbulence and shear forces acting on the filter material such that the particles become desorbed from the filter material and become suspended in the liquid medium. The method may be used to recover biological particles, such as leucocytes and blood platelets, from filter materials on which they are retained by adsorption. The recovered particles may then be used in diagnostic testing and analytical techniques.
Patent DE-69405653-T2 (DE)
Inventor: CERVOS ERIC
IPC: A61K47/42
Filed: 1994-07-06
Granted: 1998-02-05
Abstract: The invention consists in passing an oil-in-water emulsion through a nozzle so as to form spherules which are allowed to fall countercurrentwise in cold air and are recovered in an aqueous solution containing a crosslinking agent.
Patent DE-69408895-T2 (DE)
Inventor: GANE PATRICK ARTHUR CHARLES
IPC: B41M5/132
Filed: 1994-04-18
Granted: 1998-06-25
Abstract: There is disclosed a coating composition for the preparation of a CF sheet (i.e. a receiving sheet) of a carbonless paper copying system comprising a CF sheet and a CB sheet (i.e. a donating sheet). The coating composition comprises a colour developer and an extender, wherein the extender comprises a particulate inorganic material which has been modified by treatment with a treating agent which has (i) a non-polar hydrophobic portion comprising at least one hydrocarbon group having a chain length of from 8 to 30 carbon atoms and (ii) a polar portion which is capable of binding with sites on the surface of the pigment particles.
Patent DE-69424309-T2 (DE)
Inventor: KROLL BO
IPC: G08B5/22
Filed: 1994-12-02
Granted: 2000-09-14
Abstract: In a method of transmitting data from a transmitter (1) to one or more receivers (3), the data is transmitted in the form of a row of characters of a first type which each consist of a given number of bits, and which may be received, stored and displayed in the receiver or each receiver. A second type (10) character is additionally transmitted, as needed, said character being received and stored in the receiver or each receiver together with the first type characters. Said character of second type (10) contains bits which are then combined with at least one individual succeeding or preceding first type character in such a manner that said individual first type character is extended to contain a larger number of bits than the number of bits transmitted for the characters concerned. <IMAGE>
Patent DE-69429507-T2 (DE)
Inventor: VOLKONSKY VIKTOR ALEXEEVICH
IPC: A61K9/18
Filed: 1994-01-26
Granted: 2002-05-16
Abstract: A magnetically controllable, or guided, carrier composition and methods of use and production are disclosed, the composition for carrying biologically active substances to a treatment zone in a body under control of a magnetic field. The composition comprises composite, volume-compounded ferrocarbon particles of 0.2 to 5.0  mu m in size, and preferably between 1.0 and 4.0  mu m, containing 1.0 to 95.0% by volume of carbon, and preferably between about 20 and 50%. The particles are produced by a joint deformation of a mechanical mixture of iron and carbon powders. The obtained particles are placed in a solution of a biologically active substance to absorb the substance onto the particles. The combination is administered in suspension.
Patent DE-69500962-T2 (DE)
Inventor: BOUVIER DANIEL
IPC: B65D55/02
Filed: 1995-01-05
Granted: 1998-04-16
Abstract: The stopper comprises a top (1) with a tapping (2). A cap (3) which rotates freely in one direction on the screw top has an opening (4) in its top (5). An elastic ring (6) which is housed in a groove in the internal lateral face of the cap mates with the lower edge (7) of the top so as to prevent the top from leaving the cap . The upper face of the top has a dihedral part (8) constituting a male part. The cap has an upper sleeve (9), having the same axis (XX') as the cap, whose two bosses (10) overhang the male part. The key for the removal of the stopper has a female part of complementary form to the dihedral part of the male top and indentations conjugate with the bosses.
Patent DE-69533284-T2 (DE)
Inventor: VOLKMANN ROBERT A
IPC: C07D333/24
Filed: 1995-03-20
Granted: 2005-07-21
Abstract: PCT No. PCT/IB95/00189 Sec. 371 Date Feb. 19, 1997 Sec. 102(e) Date Feb. 19, 1997 PCT Filed Mar. 20, 1995 PCT Pub. No. WO95/29909 PCT Pub. Date Nov. 9, 1995This invention relates to compounds of formula (IA), (IB), (IC) or (ID), wherein m, X, Z, R2, R3, R4, R5, R6, R14 and the dotted lines are as defined below, their pharmaceutically acceptable salts, pharmaceutical compositions containing them and methods of using them to treat Alzheimer's disease, age-associated memory impairment, Parkinson's disease and other central nervous system disorders. The claimed compounds have the ability to enhance the release of neurotransmitters such as acetylcholine, dopamine and serotonin.    <IMAGE>  (IA)
Patent DE-69612497-T2 (DE)
Inventor: LANGLET ABRAHAM
IPC: C06B31/00
Filed: 1996-07-26
Granted: 2001-10-18
Abstract: PCT No. PCT/SE96/00976 Sec. 371 Date Jan. 13, 1998 Sec. 102(e) Date Jan. 13, 1998 PCT Filed Jul. 26, 1996 PCT Pub. No. WO97/06099 PCT Pub. Date Feb. 20, 1997The invention relates to a method of preparing dinitramidic acid HN(NO2)2 and salts thereof having the formula M+n(-N(NO2)2)n, wherein M is a metal cation or a nitrogen-containing cation and n=1-3. The dinitramide salt can be used as oxidiser in solid propellants. Dinitramidic acid is prepared by nitration of a compound selected from a group consisting of NH2NO2, NH4NH2CO2; NH2SO3H, NH(SO3H)2, N(SO3H)3, and its salts with metal cations or organic cations, e.g. NH(SO3NH4)2, and other products formed when ammonia is reacted with sulphuric trioxide, with a common nitrating acid such as nitric acid/sulphuric acid or nitric acid/acetic anhydride. The invention also relates to a method of preparing dinitramide salt, comprising neutralisation of dinitramidic acid with a neutralising agent, e.g. ammonia, and recovery of the dinitramide salt from a mixture of salts formed in the neutralisation. An aqueous solution of the salt mixture is passed through a column containing an adsorbing agent which adsorbs the dinitramide salt and is selected from a class consisting of activated carbon, silica gel and zeolites. The dinitramide salt is eluted with an elution agent consisting of hot water and/or a polar organic solvent, e.g. acetone, acetonitrile, 2-propanol and other lower alcohols and mixtures thereof.
Patent DE-69615040-T2 (DE)
Inventor: MAUBRU MIREILLE
IPC: A61Q5/04
Filed: 1996-10-21
Granted: 2002-03-21
Abstract: The present invention relates to a novel vesicle-free composition for the first stage of a process of permanent reshaping of keratin fibres, this composition comprising, in a suitable cosmetic support, at least one compound of ceramide type in a specific amount and at least one reducing agent.The invention also relates to a novel process of permanent reshaping of keratin fibres using the composition defined above.
Patent DE-69617298-T2 (DE)
Inventor: DEAR AIDEN ROBERT
IPC: B21J15/16
Filed: 1996-03-15
Granted: 2002-07-25
Abstract: Riveting apparatus of the type in which an elongated mandrel (30), having an enlarged head at one end and loaded with a plurality of the tubular rivets (40) forming a column of rivets on the mandrel, is gripped by gripping means (43) at or near the end remote from the head, and reciprocated relative to an abutment (32) by relative reciprocation between the gripping means (43) and the abutment (32), the rivets (40) in the column being fed forwardly along the mandrel (30) so that the leading rivet nearest the mandrel head is positioned between the mandrel head and the abutment (32) and can then be set by moving the mandrel (30) rearwardly relative to the abutment (32) so as to draw the head of the mandrel through the bore of the rivet (40) while the rivet is supported by the abutment (32); includes means (55) for feeding rivets (40) forwardly along the mandrel (30), and an abutment (32) provided by a plurality of members (28, 28) movable between a closed position (Fig. 3A) in which they provide an abutment (32) to support a rivet (40) as aforesaid and an open position (Fig. 3B) in which they allow the free passage of rivets (40) between them, and is provided with a control system (12) operatively connected to the appropriate elements of the apparatus (11) for controlling their operation respectively, the control system (12) including an actuation device (PB.4), such that, upon actuation by an operator of the actuation device (PB.4) the control system (12) controls the riveting apparatus (11) so that the rivet feeding means (55) is activated or de-activated, the abutment members (28, 28) are closed or opened, and the mandrel gripping means (43) is activated or de-activated, with a time delay between each step, to enable rapid removal and replacement of the mandrel (30).
Patent DE-69618969-T2 (DE)
Inventor: DEWEZ JACQUES
IPC: D06M15/507
Filed: 1996-08-19
Granted: 2002-09-19
Abstract: Fabric softening compositions which form and maintain stable aqueous dispersions in the absence of added oily perfume are disclosed. The stability of aqueous fabric softener compositions based on a mixture of an amido amine, such as bis(tallow amidoethyl)-2-hydroxyethyl amine and a quaternary diester fabric softener, such as N-methyl, N,N,N-triethanolamine ditallow ester quaternary ammonium salt is enhanced by inclusion in the composition of at least one fatty ester of a fatty acid or fatty alcohol, e.g., glycerol monostearate.
Patent DE-69703662-T2 (DE)
Inventor: APPELTANS GUY
IPC: E05G1/14
Filed: 1997-08-26
Granted: 2001-06-07
Abstract: The invention concerns a protective device for valuable documents, including a volume capable of being closed and divided into two compartments, one of the compartments being used to receive the documents to be protected while in the second compartment caps contain a pyrotechnic mixture which, when the device is wrongly manipulated, will burst into a flame which will penetrate the documents in the first mentioned compartment.
Patent DE-69712171-T2 (DE)
Inventor: CHIOCCI JEAN MARIE
IPC: B01D5/00
Filed: 1997-12-04
Granted: 2002-11-28
Abstract: Apparatus for regenerating solvents comprises an upright vessel (2) with an upper inlet (3), by which the solvents in vapour phase enter the vessel from external plant to be mainly condensed in heat exchanger (9). Residual gas is drawn out through a second heat exchanger (10), which condenses the remaining vapour. The liquid from both heat exchangers flows down collector (17) into settling vessel (20), from which heavy and light fractions are transferred into storage compartments (24,25) at the bottom of the vessel. At least one compartment has a heat exchanger (27) to cool its contents before they are recycled to the plant.
Patent DE-69715316-T2 (DE)
Inventor: HOLM-LARSEN HELGE
IPC: F02C6/00
Filed: 1997-06-14
Granted: 2003-01-02
Abstract: A method for the combined production of synthesis gas and electrical power including at least   a step for the production of synthesis gas by combusting a second fuel stream with combustion air to flue gas and passing the flue gas in heat conducting relationship with steam reforming reactions of a hydrocarbon feedstock in a heat exchange reactor, and a step for the production of electrical power by combusting a first fuel stream with combustion air in a gas turbine combustion chamber to a flue gas and expanding the flue gas in a gas turbine; wherein the flue gas from one of the steps is used as combustion air in the other step.
Patent DE-69725734-T2 (DE)
Inventor: CATHEY A
IPC: H01J1/304
Filed: 1997-08-20
Granted: 2004-08-05
Abstract: A semiconductor device for use in field emission displays includes a substrate formed from a semiconductor material, glass, soda lime, or plastic. A first layer of a conductive material is formed on the substrate. A second layer of microcrystalline silicon is formed on the first layer. This layer has characteristics that do not fluctuate in response to conditions that vary during the operation of the field emission display, particularly the varying light intensity from the emitted electrons or from the ambient. One or more cold-cathode emitters are formed on the second layer.
Patent DE-69727691-T2 (DE)
Inventor: LACEY L
IPC: A61P1/04
Filed: 1997-10-15
Granted: 2004-07-22
Abstract: The present invention concerns the use of a KGF-2 protein(s) as a therapeutic agent, suitably formulated in a pharmaceutical composition, for the specific treatment of disease states and medical conditions afflicting tissues and organs such as in the eye, ear, gums, pancreas, urinary bladder, liver and gastrointestinal tract.
Patent DE-69731312-T2 (DE)
Inventor: CASSELS FREDERICK
IPC: C07K7/00
Filed: 1997-08-01
Granted: 2005-05-04
Abstract: This invention relates to amino acid sequences from within a consensus peptide of the formula: VEKNITVTASVDPTIDLLQADGSALPSAVALTYSPA (Seq. #1). Eight mer peptides from within the consensus peptide were tested against an antibody raised to the consensus peptide. Studies relating to antibody raised to denatured proteins from the natural organisms producing the family of proteins were also useful and showed particular value of some sequences. A sequence of the formula ASVDPTIDLLQA (Seq. #2) was identified thereby. An enlarged sequence of the formula TVTASVDPTIDLLQAD (Seq. #3) is also especially interesting as are intermediate sequences such as sequences VTASVDPTIDLLQAD (Seq. #4), TASVDPTIDLLQAD (Seq. #5), and TASVDPTIDLLQA (Seq. #6) as being binding sites for antibodies raised to the denatured proteins.
Patent DE-69736474-T2 (DE)
Inventor: WANG YI
IPC: C07K14/73
Filed: 1997-06-03
Granted: 2007-01-18
Abstract: This invention is directed to monoclonal antibodies produced by using CD4-expressing T lymphocytes, such as peripheral blood mononuclear T cells, thymocytes, splenocytes and leukemia or lymphoma derived T cell line cells such as HPB-ALL or SUP-T as the immunogen in accordance with the protocols and screening procedures described. The monoclonal antibodies of the present invention are characterized by their ability to neutralize in vitro and in vivo primary isolates of Human Immunodeficiency Virus (HIV) and related immunodeficiency viruses. The antibodies are directed against a host cell antigen complex comprising CD4 protein in association with domains from chemokine receptors and have broad neutralizing activities against primary isolates from all clades of HIV type 1 (HIV-1) and primary isolates of HIV type 2 (HIV-2) and Simian Immunodeficiency Virus (SIV). The present invention is also directed to a method of selecting and producing such antibodies, hybridomas which secrete such antibodies, pharmaceutical compositions comprising such antibodies and methods for pre- and post-exposure prevention of immunodeficiency virus infection in primates, including humans, by such antibodies whose primary targets are CD4-expressing lymphocytes.                                              00000
Patent DE-69808144-T2 (DE)
Inventor: PETERSSON ULF
IPC: A47L9/00
Filed: 1998-12-30
Granted: 2003-05-15
Abstract: A docking system (1) according to the invention comprises   a) at least one self-propelled working-tool (3), preferably intended for attendance of ground or floor, such as grass-cutting, moss-scratching, watering, vacuum-cleaning, polishing, transportation etc., having a body (16) and b) at least one docking station (2) for the at least one working tool (3), c) wherein the docking station and the tool can by way of emitted signals cstablish contact with each other, so that the tool can drive up to the docking station, d) wherein the docking station is provided with at least one first transmission part (5, 6; 5', 6') and the working tool is provided with at least one cooperating second transmission part (7, 8) for transmission of energy and/or information between the docking station and the working tool, e) wherein the docking station is provided with at least one rising part (10, 11, 12, 13), of which at least one part is used for mounting of the first transmission part(s). f) wherein the tool's second transmission part(s) (7, 8) is/are located on the upper side of the body.   <IMAGE>
Patent DE-69809744-T2 (DE)
Inventor: HEMMERICH LUDWIG
IPC: G01K17/00
Filed: 1998-07-02
Granted: 2003-04-10
Abstract: The present invention relates to a device for measuring heat evolution in a homogenous fluid sample. The device comprises: (i) a first chamber having a heat capacity C1 and an internal surface of area A1 defining a cavity for containing a volume V1 of the said fluid; (ii) a second chamber having a heat capacity C2 and an internal surface of area A2 defining a cavity for containing a volume V2 of the said fluid, wherein C1 is approximately equal to C2, A1 is approximately equal to A2 and V1 is greater than V2; (iii) means to detect and measure heat flow between the first and second chambers; and (iv) means to achieve a temperature equilibration between the two chambers.
Patent DE-69814352-T2 (DE)
Inventor: RUEGER C
IPC: A61L27/00
Filed: 1998-02-05
Granted: 2004-03-25
Abstract: The present invention provides the use of a matrix-free composition lacking a scaffolding structure comprising an osteogenic protein dispersed in a biocompatible non-rigid, amorphous carrier having no defined surfaces for the preparation of pharmaceutical compositions for filling a defect locus, for repairing chondral or osteochondral defects or for accelerating cartilage formation at a defect locus.
Patent DE-69821142-T2 (DE)
Inventor: BAXTER GORDON SMITH
IPC: A61K31/4045
Filed: 1998-09-25
Granted: 2004-11-11
Abstract: The present invention provides for the treatment of primary headache disorders, particularly migraine, using antagonists of the EP4 receptor for prostaglandin E2. Particular EP4 receptor antagonists include azole compounds of formula (I): wherein R1 is a group such as lower alkyl substituted with carboxy; R2 is hydrogen or lower alkyl, R3 and R4 are aryl optionally substituted with halogen, Q is in which -A1- is a single bond or lower alkylene, is a cyclo group, -A3- is a single bond or lower alkylene, and X is O, NH or S; or a salt or its solvate thereof.
Patent DE-69829406-T2 (DE)
Inventor: GOLDMAN MICHEL
IPC: C07D295/16
Filed: 1998-11-25
Granted: 2006-03-02
Abstract: The invention concerns a method for inhibiting cytokine production by cells, in particular animal or human cells, and their secretion, which consists in applying on said cells at least an azo compound derivatives corresponding to formula (I), in which A represents a carboxyl or a group (a); B represents a carboxyl or a group (b); R1, R2, R3 and R4=H, Hal, OH or a hydrocarbon radical, R1 and R2 as well as R3 and R4 capable of being a heterocyclic ring; X1 and X2=O or NR5, where R5=H, Hal, a hydrocarbon radical or a nitro group.
Patent DE-69833784-T2 (DE)
Inventor: BLINKOVSKY ALEXANDER
IPC: A23J3/34
Filed: 1998-11-13
Granted: 2006-10-19
Abstract: The present invention relates to isolated polypeptides having aminopeptidase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing and using the polypeptides.
Patent DE-69835142-T2 (DE)
Inventor: SAMSOONDAR JAMES
IPC: G01N21/35
Filed: 1998-03-03
Granted: 2007-06-06
Abstract: An apparatus and a method whereby plasma integrity of plasma contained in a blood bag is rapidly and accurately assessed without compromising the sterility of the plasma, or destroying any of its components. This is achieved through spectral data which is used in a novel way so as to determine if a plasma specimen representative of plasma in a blood bag contains interferents and if so, to what extent. The apparatus and method analyse plasma contained in two bags whereby tubing connects the two bags. A lamp is used to irradiate the specimen, and a spectrophotometer is used to measure radiation from the specimen. The apparatus and method allow for determination where both the bags and tubings are translucent and contain writing on their surfaces (e.g., proprietary information), and the light is transmitted through the writings, plastic, and the plasma contained in the bag or tubing.
Patent DE-69835663-T2 (DE)
Inventor: SCHECHTER ISRAEL
IPC: G01N21/71
Filed: 1998-01-09
Granted: 2007-09-13
Abstract: A method for on-line analysis of polycyclic aromatic hydrocarbons (PAH) in aerosols. The aerosols are collected on non-fluorescing filter paper, excited to fluorescence and imaged spectrally. The images are compared with spectra in a database to determine and quantify the PAH species present. The scope of the invention is broader than fluorescence, and includes excitation analysis of particulate matter generally.